CC
ADPT icon

Centiva Capital’s Adaptive Biotechnologies ADPT Stock Holding History

Centiva Capital’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,635
Closed -$80.1K – 1612
2024
Q3 		$80.1K Buy
+15,635
New +$68.1K ﹤0.01% 1977
2024
Q2 		– Sell
-60,465
Closed -$194K – 2025
2024
Q1 		$194K Buy
+60,465
New +$234K 0.01% 1491
2023
Q4 		– Sell
-22,579
Closed -$123K – 1743
2023
Q3 		$123K Buy
+22,579
New +$149K 0.01% 1485
2021
Q2 		– Sell
-32,211
Closed -$1.3M – 1359
2021
Q1 		$1.3M Buy
32,211
+25,520
+381% +$1.38M 0.18% 271
2020
Q4 		$396K Buy
+6,691
New +$345K 0.05% 558

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return